9188

antibody from Cell Signaling Technology, Inc

Targeting: PTEN BZS, MHAM, MMAC1, PTEN1, TEP1

Western blot (Data presented on provider website)

Immunoprecipitation (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

9188

Provider

Cell Signaling Technology, Inc

Proper citation

Cell Signaling Technology Cat#9188, RRID:AB_2253290

Product name

PTEN (D4.3) XP® Rabbit mAb

Antibody type

Monoclonal

Reactivity

Human, Mouse, Rat, Canine, Simian

Host

Rabbit

Storage

-20°C

References

Submitted references

Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia.

Lotan TL, Gumuskaya B, Rahimi H, Hicks JL, Iwata T, Robinson BD, Epstein JI, De Marzo AM
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013 Apr;26(4):587-603

---

PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis.

Lan R, Geng H, Polichnowski AJ, Singha PK, Saikumar P, McEwen DG, Griffin KA, Koesters R, Weinberg JM, Bidani AK, Kriz W, Venkatachalam MA
American journal of physiology. Renal physiology 2012 May 1;302(9):F1210-23

---

PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients.

Lotan TL, Gurel B, Sutcliffe S, Esopi D, Liu W, Xu J, Hicks JL, Park BH, Humphreys E, Partin AW, Han M, Netto GJ, Isaacs WB, De Marzo AM
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Oct 15;17(20):6563-73